Expansion and activation of natural killer cells from PBMC for immunotherapy of hepatocellular carcinoma

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 14

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

412

HTML

3168

Figures (1-3)

265

Tables (1-2)

213

Sum=4058

Jul 15, 2004 (publication date) through Dec 2, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Reports

World J Gastroenterol. Jul 15, 2004; 10(14): 2119-2123
Published online Jul 15, 2004. doi: 10.3748/wjg.v10.i14.2119

Table 1 Proportion of CD16+CD56+ cells compared to other cell groups after NK cell expansion cultures

Irradiated target cells used for expansion culture	Cell proportion in lymphocyte populations (%)
Irradiated target cells used for expansion culture	CD3+CD56-	CD3-CD56+	CD3+CD56+	CD16+CD56+
HFWT	15.2	72.0	12.3	72.7
HCC-2	49.7	18.5	31.1	22.8

Citation: Peng BG, Liang LJ, He Q, Huang JF, Lu MD. Expansion and activation of natural killer cells from PBMC for immunotherapy of hepatocellular carcinoma. World J Gastroenterol 2004; 10(14): 2119-2123
URL: https://www.wjgnet.com/1007-9327/full/v10/i14/2119.htm
DOI: https://dx.doi.org/10.3748/wjg.v10.i14.2119